New Zealand markets closed

GE HealthCare Technologies Inc. (GEHC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
78.75-1.10 (-1.38%)
At close: 04:00PM EDT
78.52 -0.23 (-0.29%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 35.95B
Enterprise value 43.07B
Trailing P/E 23.21
Forward P/E 18.55
PEG ratio (5-yr expected) 6.19
Price/sales (ttm)1.88
Price/book (mrq)4.92
Enterprise value/revenue 2.23
Enterprise value/EBITDA 12.55

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-0.96%
S&P500 52-week change 326.94%
52-week high 394.50
52-week low 362.35
50-day moving average 384.87
200-day moving average 376.47

Share statistics

Avg vol (3-month) 32.98M
Avg vol (10-day) 31.68M
Shares outstanding 5456.46M
Implied shares outstanding 6456.46M
Float 8425.15M
% held by insiders 16.94%
% held by institutions 177.32%
Shares short (15 May 2024) 410.36M
Short ratio (15 May 2024) 43.56
Short % of float (15 May 2024) 42.89%
Short % of shares outstanding (15 May 2024) 42.27%
Shares short (prior month 15 Apr 2024) 410.95M

Dividends & splits

Forward annual dividend rate 40.12
Forward annual dividend yield 40.15%
Trailing annual dividend rate 30.12
Trailing annual dividend yield 30.15%
5-year average dividend yield 4N/A
Payout ratio 43.49%
Dividend date 315 May 2024
Ex-dividend date 418 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.05%
Operating margin (ttm)13.85%

Management effectiveness

Return on assets (ttm)5.62%
Return on equity (ttm)22.39%

Income statement

Revenue (ttm)19.5B
Revenue per share (ttm)42.80
Quarterly revenue growth (yoy)-1.20%
Gross profit (ttm)N/A
EBITDA 3.52B
Net income avi to common (ttm)1.57B
Diluted EPS (ttm)3.39
Quarterly earnings growth (yoy)0.50%

Balance sheet

Total cash (mrq)2.55B
Total cash per share (mrq)5.59
Total debt (mrq)9.67B
Total debt/equity (mrq)127.23%
Current ratio (mrq)1.06
Book value per share (mrq)16.23

Cash flow statement

Operating cash flow (ttm)2.05B
Levered free cash flow (ttm)1.79B